HEADQUARTERED IN ONTARIO, CANADA, PROLLENIUM® IS COMMITTED EXCLUSIVELY TO THE DEVELOPMENT AND GLOBAL COMMERCIALIZATION OF THE REVANESSE® BRAND OF HYALURONIC ACID (HA) DERMAL FILLERS AND IS RESHAPING THE AESTHETIC EXPERIENCE.
THEIR INVESTMENT INTO RESEARCH AND DEVELOPMENT, FROM UNIQUE CROSS-LINKING PROCESSES, TO THE SPHERICAL NATURE OF PARTICLES, HAS LED TO CUTTING-EDGE ADVANCEMENTS DESIGNED TO ENHANCE TREATMENT OUTCOMES FOR DERMAL FILLER PATIENTS.
HAVING SOLD OVER 4 MILLION SYRINGES WORLDWIDE, THE REVANESSE® FAMILY OF PRODUCTS ARE NOW PRESENT IN OVER 80 COUNTRIES AROUND THE GLOBE.
In a clinical trial, 50% more patients treated with a comparative product experienced swelling, than patients who were treated with Revanesse® Versa™. 1
You may find that Revanesse® Versa™ will help in the improvement of your nasolabial folds (laugh lines) for up to 12 months with optimal correction. 2
DESIGNED FOR SAFETY
The Revanesse® Versa™ formula is well-studied, with over 300 patients of multiple skin types, treated in three clinical trials, with no serious adverse events reported.
A Revanesse® Versa™ treatment is minimally invasive and provides immediate results. Take control of the signs of aging and ask your healthcare provider if Revanesse® Versa™ is right for you.
Revanesse® Versa™ is the only hyaluronic acid (HA) dermal filler in the US available in a 1.2mL syringe size.
Whether you require more product to be brought to full correction or are seeking a more cost-effective treatment option; 20% more product in our syringe is another example of the Revanesse® difference and our commitment to providing pathways for patients to achieve the best possible results.